View PDF Version - RePub - Erasmus Universiteit Rotterdam

Introduction 23
17. Ohto H, Terazawa S, Sasaki N, Hino K, Ishiwata C, Kako M, Ujiie N, Endo C, Matsui A, et
al. Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of
Hepatitis C Virus Collaborative Study Group. N Engl J Med 1994;330:744-50.
18. Hellard M, Aitken C, Mackintosh A, Ridge A, Bowden S. Investigation of infection control
practices and knowledge of hepatitis C among body-piercing practitioners. Am J Infect
Control 2003;31:215-20.
19. Sawayama Y, Hayashi J, Kakuda K, Furusyo N, Ariyama I, Kawakami Y, Kinukawa N, Kashiwagi
S. Hepatitis C virus infection in institutionalized psychiatric patients: possible role of transmission
by razor sharing. Dig Dis Sci 2000;45:351-6.
20. Vandelli C, Renzo F, Romano L, Tisminetzky S, De Palma M, Stroffolini T, Ventura E, Zanetti
A. Lack of evidence of sexual transmission of hepatitis C among monogamous couples:
results of a 10-year prospective follow-up study. Am J Gastroenterol 2004;99:855-9.
21. Fattovich G, Giustina G, Degos F, Diodati G, Tremolada F, Nevens F, Almasio P, Solinas A,
Brouwer JT, Thomas H, Realdi G, Corrocher R, Schalm SW. Effectiveness of interferon alfa
on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European
Concerted Action on Viral Hepatitis (EUROHEP). J Hepatol 1997;27:201-5.
22. National Institutes of Health Consensus Development Conference Panel statement: management
of hepatitis C. Hepatology 1997;26:2S-10S.
23. WHO. Hepatitis C. Global prevalence (update). Weekly Epidemiological Record, 2000.
24. Veldt BJ, Saracco G, Boyer N, Camma C, Bellobuono A, Hopf U, Castillo I, Weiland O, Nevens
F, Hansen BE, Schalm SW. Long term clinical outcome of chronic hepatitis C patients with
sustained virological response to interferon monotherapy. Gut 2004;53:1504-8.
25. Harrell FE. Regression Modelling Strategies. Springer, 2002.
26. Steyerberg EW. Clinical Prediction Models. Springer, 2009.
27. Mauryama NT, F. Takeuchi M. Prediction of an outcome using trajectories estimated from a
linear mixed model. Journal of Biopharmaceutical Statistics 2009;19:779-790.
28. Morrell CH, Brant LJ, Sheng S. Comparing approaches for predicting prostate cancer from
longitudinal data, In Proceedings of the American Statistical Association, Alexandria, 2007.,
American Statistica Association, 2007.
29. Robins JM, Blevins D, Ritter G, Wulfsohn M. G-estimation of the effect of prophylaxis
therapy for Pneumocystis carinii pneumonia on the survival of AIDS patients. Epidemiology
1992;3:319-36.
30. Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in
epidemiology. Epidemiology 2000;11:550-60.
31. Hernan MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect
of zidovudine on the survival of HIV-positive men. Epidemiology 2000;11:561-70.
32. Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, Perelson AS. Hepatitis C viral
dynamics in vivo and the antiviral effi cacy of interferon-alpha therapy. Science 1998;282:103-7.